Multimodality imaging in cardiac sarcoidosis: A case series of diverse phenotypes.

Hongyan Qiao, Hao Tian, Mengdi Jiang, Jinghui Li, Tian Lan, Minjie Lu
Author Information
  1. Hongyan Qiao: Department of Magnetic Resonance Imaging, Fuwai Hospital, Beijing, Jiangsu, China.
  2. Hao Tian: Department of Medical Imaging, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
  3. Mengdi Jiang: Department of Magnetic Resonance Imaging, Fuwai Hospital, Beijing, Jiangsu, China.
  4. Jinghui Li: Department of Magnetic Resonance Imaging, Fuwai Hospital, Beijing, Jiangsu, China.
  5. Tian Lan: Department of Magnetic Resonance Imaging, Fuwai Hospital, Beijing, Jiangsu, China.
  6. Minjie Lu: Department of Magnetic Resonance Imaging, Fuwai Hospital, Beijing, Jiangsu, China.

Abstract

Cardiac sarcoidosis (CS) represents a rare yet potentially life-threatening condition characterized by non-specific clinical symptoms that maybe easily missed by clinicians. In this case series, the clinical presentations, various imaging modalities' characteristics, and the management of four patients, each with distinct phenotypes of CS confirmed through endomyocardial biopsy, are discussed. Advanced imaging techniques, including positron emission tomography, revealed the focal septal uptake of F fluorodeoxyglucose, which suggests an ongoing inflammation, whereas contrast-enhanced cardiac magnetic resonance demonstrates septal late gadolinium enhancement, which indicates replacement fibrosis. These features of multimodality imaging in CS can assist in patient diagnosis and treatment.

Keywords

References

  1. Pharmaceuticals (Basel). 2021 Dec 09;14(12): [PMID: 34959686]
  2. JACC Cardiovasc Imaging. 2011 Feb;4(2):150-6 [PMID: 21329899]
  3. Respir Med. 2022 Jul;198:106864 [PMID: 35550245]
  4. J Nucl Cardiol. 2020 Dec;27(6):2103-2115 [PMID: 30603894]
  5. Eur Heart J. 2023 May 1;44(17):1495-1510 [PMID: 36924191]
  6. ESC Heart Fail. 2020 Oct;7(5):2662-2671 [PMID: 32578957]
  7. N Engl J Med. 2021 Sep 9;385(11):1018-1032 [PMID: 34496176]
  8. Circ J. 2019 Oct 25;83(11):2329-2388 [PMID: 31597819]
  9. Circ Cardiovasc Imaging. 2016 Nov;9(11): [PMID: 27903537]
  10. Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):757-767 [PMID: 29319785]
  11. ESC Heart Fail. 2020 Jun;7(3):1362-1370 [PMID: 32343481]
  12. J Am Coll Cardiol. 2020 Aug 18;76(7):778-780 [PMID: 32792074]
  13. J Am Coll Cardiol. 2020 Aug 18;76(7):767-777 [PMID: 32792073]
  14. J Clin Med. 2024 Mar 22;13(7): [PMID: 38610600]
  15. Europace. 2020 Sep 1;22(9):1376-1383 [PMID: 32898252]
  16. Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1073-1089 [PMID: 28984894]
  17. Heart Rhythm. 2014 Jul;11(7):1305-23 [PMID: 24819193]
  18. Radiology. 2022 Sep;304(3):566-579 [PMID: 35579526]
  19. Eur Radiol. 2020 Jul;30(7):3702-3710 [PMID: 32166494]
  20. J Nucl Cardiol. 2022 Oct;29(5):2132-2144 [PMID: 34228338]

Word Cloud

Created with Highcharts 10.0.0imagingCardiacCSsarcoidosisclinicalcaseseriesphenotypestechniquesseptalcardiacresonancerepresentsrareyetpotentiallylife-threateningconditioncharacterizednon-specificsymptomsmaybeeasilymissedclinicianspresentationsvariousmodalities'characteristicsmanagementfourpatientsdistinctconfirmedendomyocardialbiopsydiscussedAdvancedincludingpositronemissiontomographyrevealedfocaluptakeFfluorodeoxyglucosesuggestsongoinginflammationwhereascontrast-enhancedmagneticdemonstrateslategadoliniumenhancementindicatesreplacementfibrosisfeaturesmultimodalitycanassistpatientdiagnosistreatmentMultimodalitysarcoidosis:diverseHeartfailureMagnetic

Similar Articles

Cited By